Question 1. How does nutritional status influence the development of cystic fibrosis? Pathophysiological aspect of nutritional disorders in cystic fibrosis;Question 1: Quelle influence de l'état nutritionnel sur l'évolution de la mucoviscidose?: Aspect physiopathologique des troubles nutritionnels au cours de la mucoviscidose

Archives de Pediatrie

Volumn 10, Issue SUPPL. 3, 2003, Pages

  Turck, D ^a  

^a UNIV LILLE   (France)

Author keywords

Cystic fibrosis; Nutrition; Pathophysiology

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

CONFERENCE PAPER; CYSTIC FIBROSIS; DIETARY INTAKE; ENERGY TRANSFER; GENE MUTATION; GENOTYPE; GLYCOGEN METABOLISM; NUTRITIONAL REQUIREMENT; NUTRITIONAL STATUS; PANCREAS INSUFFICIENCY; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PSEUDOMONAS AERUGINOSA; REGULATORY MECHANISM;

EID: 0141570864     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(03)90630-0     Document Type: Conference Paper

References (83)

1. Beker LT, Russek-Cohen E, Fink RJ. Stature as a prognostic factor in cystic fibrosis survival. J Am Diet Assoc 2001; 101: 438-42.
2. Corey M, Mc Laughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol 1988; 41: 583-91.
3. Kerem E, Reisman J, Corey M, Canny GJ, Levison H. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992; 326: 1187-91.
4. Kraemer R, Rudeberg A, Hadorn B, Rossi E. Relative underweight in cystic fibrosis and its prognostic value. Acta Paediatr Scand 1978; 67: 33-7.
5. Schöni MH, Casaulta-Aebischer C. Nutrition and lung function in cystic fibrosis patients: review. Clin Nutr 2000; 19: 79-85.
6. Munck A, Navarro, Debray D, Turck D. Prise en charge digestive et nutritionnelle. Recommandations pour la prise en charge de la mucoviscidose. Arch Pédiatr 2001; 8 Suppl 5: 838s-855s.
7. Reilly J, Edwards CA, Weaver LT. Malnutrition in cystic fibrosis: the energy-balance equation. J Pediatr Gastroenterol Nutr 1997; 25: 127-36.
8. Turck D, Michaud L. Cystic fibrosis: nutritional consequences and management. Baillieres Clin Gastroenterol 1998; 12: 805-22.
9. Gottrand F. Mesure de la dépense énergétique dans les conditions habituelles de vie chez l'enfant. Arch Pédiatr 1998; 5: 1020-2.
10. Bell SC, Saunders MJ, Elborn JS, Shale DJ. Resting energy expenditure and oxygen cost of breathing in patients with cystic fibrosis. Thorax 1996; 51: 126-31.
11. Bowler IM, Green JH, Wolfe SP, Littlewood JM. Resting energy expenditure and substrate oxidation rates in cystic fibrosis. Arch Dis Child 1993; 68: 754-9.
12. Buchdahl RM, Cox M, Fulleylove C, Marchant JL, Tomkins AM, Brueton MJ, et al. Increased resting energy expenditure in cystic fibrosis. J Appl Physiol 1988; 64: 1810-6.
13. Elborn JS, Cordon SM, Western PJ, Macdonald IA, Shale DJ. Tumour necrosis factor-α, resting energy expenditure and cachexia in cystic fibrosis. Clin Sci 1993; 85: 563-8.
14. Fried MD, Durie PR, Tsui LC, Corey M, Levison H, Pencharz PB. The cystic fibrosis gene and resting energy expenditure. J Pediatr 1991; 119: 913-6.
15. Girardet JP, Tounian P, Sardet A, Veinberg F, Grimfeld A, Tournier G, et al. Resting energy expenditure in infants with cystic fibrosis. J Pediatr Gastroenterol Nutr 1994; 18: 214-9.
16. Grunow JE, Azcue MP, Berall G, Pencharz PB. Energy expenditure in cystic fibrosis during activities of daily living. J Pediatr 1993; 122: 243-6.
17. Horswill CA, Klein CL, Zipf WB, McCoy KS. Feeding-induced changes in energy expenditure in children with cystic fibrosis. JPEN 1994; 18: 497-502.
18. Murphy MD, Ireton-Jones CS, Hilman BC, Gorman MA, Liepa GU. Resting energy expenditures measured by indirect calorimetry are higher in preadolescent children with cystic fibrosis than expenditures calculated from prediction equations. J Am Diet Assoc 1995; 95: 30-3.
19. O'Rawe A, Dodge JA, Redmond AO, McIntosh J, Brock DJ. Gene/ energy interaction in cystic fibrosis (Letter to the Editor). Lancet 1990; 335: 552-3.
20. O'Rawe A, McIntosh I, Dodge JA, Brock DJ, Redmond AO, Ward R, et al. Increased energy expenditure in cystic fibrosis is associated with specific mutations. Clin Sci 1992; 82: 71-6.
21. Shepherd RW, Holt TL, Vasques-Velasquez L, Coward WA, Prentice A, Lucas A. Increased energy expenditure in young children with cystic fibrosis. Lancet 1988; 1: 1300-3.
22. Shepherd RW, Greer RM, McNaughton SA, Wotton M, Cleghorn GJ. Energy expenditure and the body cell mass in cystic fibrosis. Nutrition 2001; 17: 22-5.
23. Stallings VA, Fung EB, Hofley PM, Scanlin TF. Acute pulmonary exacerbation is not associated with increased energy expenditure in children with cystic fibrosis. J Pediatr 1998; 132: 493-9.
24. Thomson MA, Wilmott RW, Wainwright C, Masters B, Francis PJ, Shepherd RW. Resting energy expenditure, pulmonary inflammation and genotype in the early course of cystic fibrosis. J Pediatr 1996; 129: 367-73.
25. Tomezsko JL, Stallings VA, Kawchak DA, Goin JE, Diamond G, Scanlin TF. Energy expenditure and genotype of children with cystic fibrosis. Pediatr Res 1994; 35: 451-60.
26. Vaisman N, Pencharz PB, Corey M, Canny GJ, Hahn E. Energy expenditure of patients with cystic fibrosis. J Pediatr 1987; 111: 496-500.
27. Vaisman N, Clarke R, Rossi M, Goldberg E, Zello GA, Pencharz PB. Protein turnover and resting energy expenditure in patients with under-nutrition and chronic lung disease. Am J Clin Nutr 1992; 55: 63-9.
28. Zemel BS, Kawchak DA, Cnaan A, Zhao H, Scanlin TF, Stallings VA. Prospective evaluation of resting expenditure, nutritional status, pulmonary function, and genotype in children with cystic fibrosis. Pediatr Res 1996; 40: 578-86.
29. Feigel R, Shapiro BL. Mitochondrial calcium uptake and oxygen consumption in cystic fibrosis. Nature 1979; 278: 276-7.
30. Bines JE, Truby HD, Armstrong DS, Phelan PD, Grimwood K. Energy metabolism in infants with cystic fibrosis. J Pediatr 2002; 140: 527-33.
31. Pencharz PB, Jackson R. There is no evidence of a primary defect in energy metabolism in subjects with cystic fibrosis (Editorial). J Pediatr 2002; 140: 498-9.
32. Amin N, Dozor AJ. Effects of administration of aerosolized recombinant human deoxyribonuclease on resting energy expenditure in patients with cystic fibrosis. Pediatr Pulmonol 1994; 18: 150-4.
33. Beghin L, Michaud L, Loeuille GA, Wizla-Derambure N, Sardet A, Guimber D, et al. Impact of intravenous antibiotic therapy for Pseudomonas aeruginosa pulmonary exacerbation on total daily energy expenditure in cystic fibrosis patients. 34th Annual Meeting of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition, Geneva, May 9-12, 2001. J Pediatr Gastroenterol Nutr 2001; 32: 393 (Abstract).
34. Bell SC, Bowerman AM, Nixon LE, Macdonald IA, Elborn JS, Shale DJ. Metabolic and inflammatory responses to pulmonary exacerbation in adults with cystic fibrosis. Eur J Clin Invest 2000; 30: 553-9.
35. Burdet L, Hugli O, Aubert JD, Schutz Y, Roulet M, Fitting JW. Effect of elective antibiotic therapy on resting energy expenditure and inflammation in cystic fibrosis. Eur J Pediatr 1999; 158: 711-6.
36. Castro M, Diamanti A, Gambarara M, Bella S, Lucidi V, Papadatou B, et al. Resting energy expenditure in young patients with cystic fibrosis receiving antibiotic therapy for acute respiratory exacerbations. Clin Nutr 2002; 21: 141-4.
37. Naon H, Hack S, Shelton MT, Gotthoffer RC, Gozal D. Resting energy expenditure. Evolution during antibiotic treatment for pulmonary exacerbations in cystic fibrosis. Chest 1993; 103: 1819-25.
38. Reilly JJ, Ralston JM, Paton JY, Edwards CA, Weaver LT, Wilkinson J, et al. Energy balance during acute respiratory exacerbations in children with cystic fibrosis. Eur Respir J 1999; 13: 804-9.
39. Steinkamp G, Drommer A, von der Hardt H. Resting energy expenditure before and after treatment for Pseudomonas aeruginosa infection in patients with cystic fibrosis. Am J Clin Nutr 1993; 57: 685-9.
40. Vinton NE, Padman R, Davis M, Harcke HT. Effects of Pseudomonas colonization on body composition and resting energy expenditure in children with cystic fibrosis. JPEN 1999; 23: 233-6.
41. Schols AM. TNF-α and hypermetabolism in chronic obstructive pulmonary disease. Clin Nutr 1999; 18: 255-7.
42. Vic P, Ategbo S, Gottrand F, Launay V, Loeuille GA, Elian JC, et al. Nutritional impact of antipseudomonas intravenous antibiotic courses in cystic fibrosis. Arch Dis Child 1997; 76: 437-40.
43. Konstan MW, Byard PJ, Hoppel CL, Davies PB. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 1995; 332: 848-54.
44. van Heeckeren AM, Tscheikuna J, Walenga RW, Konstan MW, Davis PB, Erokwu B, et al. Effect of Pseudomonas aeruginosa infection on weight loss, lung mechanics, and cytokines in mice. Am J Respir Crit Care Med 2000; 161: 271-9.
45. Nguyen LT, Bedu M, Caillaud D, Beaufrère, Beaujon G, Vasson MP, et al. Increased resting energy expenditure is related to plasma TNF-α concentration in stable COPD patients. Clin Nutr 1999; 18: 269-74.
46. Vaisman N, Levy LD, Pencharz PB, Tan YK, Soldin SJ, Canny GJ, et al. Effect of salbutamol on resting energy expenditure in patients with cystic fibrosis. J Pediatr 1987; 111: 137-9.
47. Richards ML, Davies PS, Bell SC. Energy cost of physical activity in cystic fibrosis. Eur J Clin Nutr 2001; 55: 690-7.
48. Ward SA, Tomezsko JL, Holsclaw DS, Paolone AM. Energy expenditure and substrate utilization in adults with cystic fibrosis and diabetes mellitus. Am J Clin Nutr 1999; 69: 913-9.
49. Britto MT, Garrett JM, Konrad TR, Majure JM, Leigh MW. Comparison of physical activity in adolescents with cystic fibrosis versus age-matched controls. Pediatr Pulmonol 2000; 30: 86-91.
50. Pencharz PB, Befall G, Vaisman N, Corey M, Canny G. Energy expenditure in children with cystic fibrosis (Letter to the Editor). Lancet 1988; 2: 513-4.
51. Bronstein MN, Davies PS, Hambidge KM, Accurso FJ. Normal energy expenditure in the infant with presymptomatic cystic fibrosis. J Pediatr 1995; 126: 28-33.
52. Spicher V, Roulet M, Schutz Y. Assessment of total energy expenditure in free-living patients with cystic fibrosis. J Pediatr 1991; 118: 865-72.
53. McCloskey M, Redmond AO, Pyper S, McCabe C, Westerterp KR, Elborn JS. Total energy expenditure in stable patients with cystic fibrosis. Clin Nutr 2002; 20: 235-41.
54. Dodge JA, O'Rawe AM. Energy requirements in cystic fibrosis. In: Dodge JA, Brock DJ, Widdicombe JH, Eds. Cystic Fibrosis-Current Topics, Volume 2. Chichester: John Wiley & Sons; 1994. p. 235-54.
55. Kerem E, Corey M, Kerem BS, Rommens J, Markiewicz J, Levison H, et al. The relation between genotype and phenotype in cystic fibrosis - analysis of the most common mutation (delta F508). N Engl J Med 1990; 323: 1517-22.
56. Gaskin K, Gurwitz D, Durie P, Corey M, Levison H, Forstner G. Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr 1982; 100: 857-62.
57. Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002; 35: 246-59.
58. 3-secretion in cystic fibrosis. Pediatr Res 1982; 16: 554-7.
59. Anthony H, Paxton S, Catto-Smith A, Phelan P. Physiological and psychosocial contributors to malnutrition in children with cystic fibrosis: review. Clin Nutr 1999; 18: 327-35.
60. Weber AM, Roy CC, Morin CL, Lasalle R. Malabsorption of bile acids in children with cystic fibrosis. N Engl J Med 1973; 289: 1001-5.
61. Murphy JL, Wootton SA, Bond SA, Jackson AA. Energy content of stools in normal healthy controls and patients with cystic fibrosis. Arch Dis Child 1991; 66: 495-500.
62. Cummings JH. Short chain fatty acids in the human colon. Gut 1981; 22: 763-79.
63. Vaisman N, Tabachnik E, Sklan D. Short chain fatty acid absorption in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 1992; 15: 146-9.
64. Parrett AM, Clarke D, Edwards CA. Colonic fermentation capacity is reduced in children with cystic fibrosis. Proc Nutr Soc 1996; 55: 49A (Abstract).
65. Wootton SA, Murphy JL, Bond SA, Ellis JE, Jackson AA. Energy balance and growth in cystic fibrosis. J R Soc Med 1991; 84 Suppl 18: 22-7.
66. Lanng S, Thorsteinsson B, Erichsen G, Nerup J, Koch C. Glucose tolerance in cystic fibrosis. Arch Dis Child 1991; 66: 612-6.
67. Moran A, Doherty L, Wang X, Thomas W. Abnormal glucose metabolism in cystic fibrosis, J Pediatr 1998; 133: 10-7.
68. Hardin DS, LeBlanc A, Lukenbaugh S, Seilheimer DK. Insulin resistance is associated with decreased clinical status in cystic fibrosis. J Pediatr 1997; 130: 948-56.
69. Sauerwein HP, Schols AM. Glucose metabolism in chronic lung disease. Clin Nutr 2002; 21: 367-71.
70. Wilson DC, Kalnins D, Stewart C, Hamilton N, Hanna AK, Durie PR, et al. Challenges in the dietary treatment of cystic fibrosis related diabetes mellitus. Clin Nutr 2000; 19: 87-93.
71. Lanng S, Thorsteinsson B, Nerup J, Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 1992; 151: 684-7.
72. Hardin DS, LeBlanc A, Lukenbaugh S, Para L, Seilheimer DK. Increased proteolysis in cystic fibrosis. Pediatrics 1998; 101: 433-7.
73. Sinaasappel M, Stern M, Littlewood JM, Wolfe S, Steinkamp G, Heijerman HGM, et al. Nutrition in patients with cyst fibrosis: a European consensus. J Cyst Fibrosis 2002; 1: 51-75.
74. Anthony H, Bines J, Phelan P, Paxton S. Relation between dietary intake and nutritional status in cyst fibrosis. Arch Dis Child 1998; 78: 443-7.
75. Bentur L, Kalnins D, Levison H, Corey M, Durie PR. Dietary intakes of young children with cystic fibrosis: is there a difference? J Pediatr Gastroenterol Nutr 1996; 22: 254-8.
76. Kawchak DA, Zhao H, Scanlin TF, Tomezsko JL, Cnaan A, Stallings VA. Longitudinal, prospective analysis of dietary intake in children with cystic fibrosis. J Pediatr 1996; 129: 119-29.
77. Ramsey BW, Farrell PM, Pencharz P and the Consensus Committee. Nutritional assessment and management in cystic fibrosis. Am J Clin Nutr 1992; 55: 108-16.
78. Shale DJ. Cytokines in cystic fibrosis. In: Dodge JA, Brock DJ, Widdicombe JH, Eds. Cystic Fibrosis-Current Topics, Volume 2. Chichester: John Wiley & Sons; 1994. p. 277-302.
79. Hankard R, Munck A, Navarro J. Nutrition and growth in cystic fibrosis. Horm Res 2002; 58 Suppl 1: 16-20.
80. Button BM, Heine RG, Catto-Smith AG, Phelan PD, Olinsky A. Postural drainage and gastro-oesophageal reflux in infants under 6 months with cystic fibrosis. Arch Dis Child 1997; 76: 148-50.
81. Heine RG, Button BM, Olinsky A, Phelan PD, Catto-Smith AG. Gastro-oesophageal reflux in infants under 6 months with cystic fibrosis. Arch Dis Child 1998; 78: 44-8.
82. Lask B. Psychological aspects of cystic fibrosis. In: Hodson ME, Geddes DM, Eds. Cystic fibrosis. Londres: Chapman & Hall Medical; 1995. p. 315-27.
83. e édition. Paris: Springer; 2001. p. 901-12.